CytoReason vs Pangea Biomed
CytoReason vs Pangea Biomed, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Pangea Biomed on 55/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 55/100
- domain rating: 40/100 against 14/100
- headcount: 116 against 16
- headcount growth: +13.7% against +2.0%
- funding raised: $128M against $12.0M
- LinkedIn following: 12,830 against 1,127
Pangea Biomed
- agent readiness: 39/100 against 21/100
At a glance
| Measure | CytoReason | Pangea Biomed |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Biotech company using AI and deep RNA analysis to predict cancer treatment response. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Oncology, Genomics, Biotech |
| Sells toBusiness model | B2B | B2B, B2C |
| Offering | Software | Software |
| Founded | 2016 | 2019 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | Pangea Biomed |
|---|---|---|
| Employees | 116 | 16 |
| Headcount growthLast 12 months | +13.7% | +2.0% |
| Total funding | $128M | $12.0M |
| Latest round | Series B | Seed |
| LinkedIn followers | 12,830 | 1,127 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Pangea Biomed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 55/100 |
| Traction | 60/100 | 48/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 30/100 | 28/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 14/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Pangea Biomed |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Segment | Not detected |
CytoReason vs Pangea Biomed: common questions
Which is better, CytoReason or Pangea Biomed?
On our 0-100 score CytoReason rates higher (68/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do CytoReason and Pangea Biomed compare on the numbers?
CytoReason leads on our overall score (68/100 against 55/100), domain rating (40/100 against 14/100), headcount (116 against 16), headcount growth (+13.7% against +2.0%), funding raised ($128M against $12.0M), LinkedIn following (12,830 against 1,127). Pangea Biomed leads on agent readiness (39/100 against 21/100).
Read the full CytoReason review and pricing or the Pangea Biomed review and pricing. You can also browse other CytoReason alternatives we track.